Cargando…

The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma

OBJECTIVE: Methylation of the promoters of SHOX2 and RASSF1A are potentially informative biomarkers for the diagnosis of early lung adenocarcinoma (LUAD). Abnormal methylation of SHOX2 and RASSF1A promoters may promote the occurrence and facilitate the progression of LUAD. MATERIALS AND METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Hong, Yang, Jun, He, Lu, Wang, Wei, Liu, Yanhong, Hu, Yue, Ge, Meiling, Ding, Jie, Ye, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273978/ https://www.ncbi.nlm.nih.gov/pubmed/35837113 http://dx.doi.org/10.3389/fonc.2022.849024

Ejemplares similares

Performance Evaluation of SHOX2 and RASSF1A Methylation for the Aid in Diagnosis of Lung Cancer Based on the Analysis of FFPE Specimen
por: Shi, Juanhong, et al.
Publicado: (2020)

DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis
por: Zhang, Chenzi, et al.
Publicado: (2017)

Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis
por: Zhao, Qing-Tao, et al.
Publicado: (2015)

Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion
por: Chen, Shaosen, et al.
Publicado: (2023)

DNA Methylation Analysis of the SHOX2 and RASSF1A Panel Using Cell-Free DNA in the Diagnosis of Malignant Pleural Effusion
por: Zhang, Nana, et al.
Publicado: (2023)

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019)

Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer
por: Feng, Hongxiang, et al.
Publicado: (2020)

Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors
por: Schneider, Katja U, et al.
Publicado: (2011)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Establishment and Application of a Prognostic Risk Score Model Based on Characteristics of Different Immunophenotypes for Lung Adenocarcinoma
por: Gao, Hong, et al.
Publicado: (2022)

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas
por: Semaan, Alexander, et al.
Publicado: (2016)

SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
por: Schmidt, Bernd, et al.
Publicado: (2010)

Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer
por: Hu, Yue, et al.
Publicado: (2022)

Expressing human SHOX in Shox2(SHOX KI)/(KI) mice leads to congenital osteoarthritis-like disease of the temporomandibular joint in postnatal mice
por: Liang, Wenna, et al.
Publicado: (2016)

Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma
por: Li, Nanhong, et al.
Publicado: (2021)

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites
por: Jung, Maria, et al.
Publicado: (2016)

Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta‐analysis update
por: Zhou, Xiaoxi, et al.
Publicado: (2021)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
por: Dietrich, Dimo, et al.
Publicado: (2013)

Variants in the 5′UTR reduce SHOX expression and contribute to SHOX haploinsufficiency
por: Babu, Deepak, et al.
Publicado: (2020)

RASSF1A and the rs2073498 Cancer Associated SNP
por: Donninger, Howard, et al.
Publicado: (2011)

A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer
por: Huang, Wenhai, et al.
Publicado: (2020)

DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma
por: Yuan, Didi, et al.
Publicado: (2021)

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma
por: Xu, Zhanyu, et al.
Publicado: (2021)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020)

Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma
por: Li, Ang, et al.
Publicado: (2021)

Prediction of the Growth Rate of Early-Stage Lung Adenocarcinoma by Radiomics
por: Tan, Mingyu, et al.
Publicado: (2021)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis
por: Li, Mingyi, et al.
Publicado: (2019)

Profiling of conserved non-coding elements upstream of SHOX and functional characterisation of the SHOX cis-regulatory landscape
por: Verdin, Hannah, et al.
Publicado: (2015)

Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
por: Weiss, Gunter, et al.
Publicado: (2017)

Skeletal Deformity Associated with SHOX Deficiency
por: Seki, Atsuhito, et al.
Publicado: (2014)

Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
por: Tan, Ruoyue, et al.
Publicado: (2021)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Integrated Multiomics Analyses Revealing Different Molecular Profiles Between Early- and Late-Stage Lung Adenocarcinoma
por: Yue, Dongsheng, et al.
Publicado: (2021)

AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
por: Ma, Chenxi, et al.
Publicado: (2020)

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
por: Krausewitz, Philipp, et al.
Publicado: (2022)

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study
por: Li, Xinyan, et al.
Publicado: (2022)

Mutational Pattern in Multiple Pulmonary Nodules Are Associated With Early Stage Lung Adenocarcinoma
por: Dong, Shao-wei, et al.
Publicado: (2021)

Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma
por: Ye, Meng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kg8dir2vracumigoul439or02c